CAN you patent an aspect of human biology? That is the question some researchers are asking in a row over an IVF patent awarded to Stanford University.
The US patent was granted to Stanford University and , a fertility clinic in Menlo Park, California, and covers the timing of certain stages of early cell division in the embryo that predict future viability. Auxogyn is confident of being awarded a European patent, too.
of the ART Institute in Washington DC, which offers IVF to US military personnel, has called for “responsible reproductive specialists� to protest against the patent. “Researchers focused on embryo kinetics should ignore the time patents claimed by Stanford,� he writes in the journal Reproductive BioMedicine Online ().
Advertisement
“Patenting software is one thing, but trying to patent cell-cycle timings is something else altogether,� says Simon Fishel at the in Nottingham, UK. “That belongs to everybody,� he says.
This article appeared in print under the headline “IVF patent fallout�